Back to Search Start Over

Laser-Assisted Prostaglandin Analogs in the Treatment of Hypopigmented Scars: A Systematic Review.

Authors :
RAMBHIA, POOJA H.
PAGAN, ANGEL D.
LAL, KARAN
GOLDBERG, DAVID
Source :
Journal of Clinical & Aesthetic Dermatology. Sep2023, Vol. 16 Issue 9, p28-32. 5p.
Publication Year :
2023

Abstract

BACKGROUND: Hypopigmented scars are challenging to treat due to a lack of effective treatments and often transient results. Recent reports suggest that prostaglandin analog-induced hyperpigmentation may have favorable dermatological applications. OBJECTIVE: Analyze previous studies involving the use of prostaglandin analogs in the treatment of hypopigmented scars. METHODS: PubMed/Medline was queried through 10/01/2022 with the following search terms: (bimatoprost AND scar), (latanoprost AND scar), (travoprost AND scar), (prostaglandin analogs AND hypopigmented scars), (PGF2alpha AND hyperpigmentation), (prostaglandin analogs AND hyperpigmentation). RESULTS: In total, 88 unique studies were reviewed for eligibility. Five studies met inclusion criteria including two prospective, double-blinded, randomized (only one was placebo-controlled), one prospective case series, one retrospective chart review, and one case report; comprising a total of 87 patients. All five studies utilized topical prostaglandin analogs as an adjunctive treatment via laser-assisted delivery. While both, the placebo-controlled and non- placebo-controlled, trials reported more than 75 percent of patients experienced at least 50 percent or more (Grade 3 or higher) improvement, the retrospective study reported 100 percent of patients experienced at least 75 percent or more (Grade 4 or higher) improvement, measured as scar repigmentation. The prospective case series and the reported single case showed overall qualitative improvement in all patients measured as repigmentation of hypopigmented and depigmented scars. LIMITATIONS: Different laser devices, parameters, treatment frequency, and follow- up timepoints. CONCLUSION: All studies evaluated demonstrated favorable treatment outcomes with no reported adverse events. Additional, large randomized controlled trials are needed to fully assess the effectiveness and long-term safety of PGF2a agonists for hypopigmented scars. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19412789
Volume :
16
Issue :
9
Database :
Academic Search Index
Journal :
Journal of Clinical & Aesthetic Dermatology
Publication Type :
Academic Journal
Accession number :
171795648